Abstract:Cardiac deletion of BSCL2 causes ATGL overexpression, excessive fatty acid oxidation (FAO), drastic reduction of cardiac lipidome and ultimately energetic and contractile dysfunction in mice. Inhibiting FAO by partial ATGL deletion or trimetazidine and increasing lipid supply via high fat diet (HFD) feeding alleviate cardiac dysfunction caused by BSCL2 deficiency. BSCL2 is a novel protein indispensable for cardiac lipid metabolism and function.BackgroundHeart failure (HF) is one of the leading causes of death worldwide and is associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip Congenital Lipodystrophy (BSCL2) disease is caused by mutations in the BSCL2 gene. Global lipodystrophic Bscl2−/− mice exhibit hypertrophic cardiomyopathy with reduced cardiac steatosis. Whether BSCL2 plays a direct role in regulating cardiac substrate metabolism and/or contractile function remains unknown.MethodsWe generated mice with cardiomyocyte‐specific deletion of Bscl2 (Bscl2cKO) and studied their cardiac substrate utilisation, bioenergetics, lipidomics and contractile function under baseline or after either a treatment regimen using fatty acid oxidation (FAO) inhibitor trimetazidine (TMZ) or a prevention regimen with high‐fat diet (HFD) feeding. Mice with partial ATGL deletion and cardiac‐specific deletion of Bscl2 were also generated followed by cardiac phenotyping.ResultsDifferent from hypertrophic cardiomyopathy in Bscl2−/− mice, mice with cardiac‐specific deletion of Bscl2 developed systolic dysfunction with dilation. Myocardial BSCL2 deletion led to elevated ATGL expression and FAO along with reduced cardiac lipid contents. Cardiac dysfunction in Bscl2cKO mice was independent of mitochondrial dysfunction and oxidative stress, but associated with decreased metabolic reserve and ATP levels. Importantly, cardiac dysfunction in Bscl2cKO mice could be partially reversed by FAO inhibitor TMZ, or prevented by genetic abolishment of one ATGL allele or HFD feeding. Lipidomic analysis further identified markedly reduced glycerolipids, glycerophospholipids, NEFA and acylcarnitines in Bscl2cKO hearts, which were partially normalised by TMZ or HFD.ConclusionsWe identified a new form of cardiac dysfunction with excessive lipid utilisation which ultimately causes cardiac substrate depletion and bioenergetics failure. Our findings also uncover a crucial role of BSCL2 in controlling cardiac lipid catabolism and contractile function and provide novel insights into metabolically treating energy‐starved HF using FAO inhibitor or HFD.

Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans

Towards a mechanistic understanding of lipodystrophy and seipin functions.

Seipin Ablation in Mice Results in Severe Generalized Lipodystrophy

Loss of the seipin gene perturbs eggshell formation in Caenorhabditiselegans

Adipose Specific Disruption of Seipin Causes Early-Onset Generalised Lipodystrophy and Altered Fuel Utilisation Without Severe Metabolic Disease.

Hepatic BSCL2 (Seipin) Deficiency Disrupts Lipid Droplet Homeostasis and Increases Lipid Metabolism via SCD1 Activity

Overexpression of a Short Human Seipin/bscl2 Isoform in Mouse Adipose Tissue Results in Mild Lipodystrophy.

Seipin differentially regulates lipogenesis and adipogenesis through a conserved core sequence and an evolutionarily acquired C-terminus.

A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation

Adipose-specific Knockout of SEIPIN/BSCL2 Results in Progressive Lipodystrophy.

SCF Slmb E3 ligase-mediated degradation of Expanded is inhibited by the Hippo pathway in Drosophila

A murine model of BSCL2-associated Celia's encephalopathy

Effects of seipin on mouse mesenchymal stem cell Osteo-Adipogenic Balance

Molecular Characterization of Seipin and Its Mutants: Implications for Seipin in Triacylglycerol Synthesis.

Abstract 191: Adipocyte Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Influences Lipid Metabolism Secondary to Changes in Expression and Function of Scavenger Receptor Class B Member 1 (SR-BI)

Caenorhabditis elegans DBL-1/BMP Regulates Lipid Accumulation via Interaction with Insulin Signaling

Seipin deficiency leads to increased endoplasmic reticulum stress and apoptosis in mammary gland alveolar epithelial cells during lactation†

BSCL2/seipin Regulates Adipogenesis Through Actin Cytoskeleton Remodelling.

BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism

Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-phosphate-o-acyltransferase-2 deficiency

Seipin regulates lipid homeostasis by ensuring calcium-dependent mitochondrial metabolism.